Prior to the SARS-CoV-2 pandemic, antibiotic resistance was listed as the major global
health care priority. Some analyses, including the O'Neill report, have predicted that deaths …

Bacterial infections are frequent in cirrhotic patients with acute decompensation or acute-on-
chronic liver failure and can complicate the clinical course. Delayed diagnosis and …

The advent of bone marrow transplant has opened doors to a different approach and offered
a new treatment modality for various hematopoietic stem-cell-related disorders. Since the …

The number of patients at risk for fungal infections continues to increase because of
improved survival of medically and surgically complex patients, new indications for …

Background Invasive aspergillosis (IA) in immunocompromised hosts carries high morbidity
and mortality. Diagnosis is often delayed because definitive diagnosis requires invasive …

Broad-range fungal PCR is a powerful tool for identifying pathogens directly from patient
specimens; however, reported estimates of clinical utility vary and costs discourage …

Aim: This rapid systematic review aimed to collect the evidence published over the last
decade on the effect of empirical antifungal therapy and its early initiation on survival rates …

Invasive fungal infection (IFI) is a significant global healthcare concern among critically ill
and immunocompromised patients. In Middle Eastern countries, IFI has been steadily …

Coronavirus disease-2019 (COVID-19)-associated pulmonary aspergillosis (CAPA) is a new
disease characterized by secondary Aspergillus mold infection in patients with COVID-19. It …

The timely and accurate diagnosis of candidemia, a severe bloodstream infection caused by
Candida spp., remains challenging in clinical practice. Blood culture, the current gold …